Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Pembrolizumab + Chemotherapy for Central Nervous System Lymphoma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing whether a new drug, Pembrolizumab, when used with chemotherapy, can effectively treat primary central nervous system lymphoma with manageable side effects. The study will involve a combination
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.